Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro

Acta Biomaterialia

Volumn 51, Issue , 2017, Pages 341-350

  Hsia, Kai ^a,b,c   Yang, Ming Jie ^b,c   Chen, Wei Min ^a   Yao, Chao Ling ^d   Lin, Chih Hsun ^b,c   Loong, Che Chuan ^b,c   Huang, Yi Long ^a   Lin, Ya Ting ^d   Lander, Arthur D ^e   Lee, Hsinyu ^a   Lu, Jen Her ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e University of California at Irvine   (United States)

Author keywords

Endothelial cell; Endothelial progenitor; Platelet adhesion; Sphingosine 1 phosphate; Syndecan 1

Indexed keywords

ADHESION; BLOOD VESSELS; CELL MEMBRANES; CYTOLOGY; DISEASES; PHOSPHOLIPIDS; PLATELETS; SCAFFOLDS (BIOLOGY); TISSUE;

DECELLULARIZED; ENDOTHELIAL PROGENITOR; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIAL-CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMAN UMBILICAL VEINS; IN-VITRO; PLATELETS ADHESIONS; SPHINGOSINE 1 PHOSPHATES; SYNDECAN-1;

ENDOTHELIAL CELLS;

CD31 ANTIGEN; MATRILYSIN; SPHINGOSINE 1 PHOSPHATE; SYNDECAN 1; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD VESSEL GRAFT; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; THROMBOCYTE ADHESION; THROMBOSIS; TISSUE ENGINEERING; UMBILICAL CORD BLOOD CELL; VEIN GRAFT; ANALOGS AND DERIVATIVES; BIOLOGICAL MODEL; BLOOD VESSEL PROSTHESIS; CELL ADHESION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOCALYX; KINETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TISSUE SCAFFOLD; ULTRASTRUCTURE; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; BLOOD VESSEL PROSTHESIS; CELL ADHESION; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOCALYX; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KINETICS; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 7; MODELS, BIOLOGICAL; PLATELET ADHESIVENESS; SPHINGOSINE; SYNDECAN-1; THROMBOSIS; TISSUE SCAFFOLDS; UMBILICAL VEINS;

EID: 85010908859     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2017.01.050     Document Type: Article

References (63)

1. [1] Yatomi, Y., Igarashi, Y., Yang, L., Hisano, N., Qi, R., Asazuma, N., Satoh, K., Ozaki, Y., Kume, S., Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121 (1997), 969–973.
2. [2] Lee, H., Goetzl, E.J., An, S., Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. Am. J. Physiol. Cell Physiol. 278 (2000), C612–C618.
3. [3] Panetti, T.S., Differential effects of sphingosine 1-phosphate and lysophosphatidic acid on endothelial cells. Biochim. Biophys. Acta 1582 (2002), 190–196.
4. [4] McVerry, B.J., Garcia, J.G., Endothelial cell barrier regulation by sphingosine 1-phosphate. J. Cell. Biochem. 92 (2004), 1075–1085.
5. [5] Siess, W., Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim. Biophys. Acta 1582 (2002), 204–215.
6. [6] Blaho, V.A., Galvani, S., Engelbrecht, E., Liu, C., Swendeman, S.L., Kono, M., Proia, R.L., Steinman, L., Han, M.H., Hla, T., HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 523 (2015), 342–346.
7. [7] Wang, W., Graeler, M.H., Goetzl, E.J., Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J. 19 (2005), 1731–1733.
8. [8] An, S., Goetzl, E.J., Lee, H., Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell. Biochem. Suppl. 30–31 (1998), 147–157.
9. [9] Lin, C.I., Chen, C.N., Lin, P.W., Lee, H., Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochem. Biophys. Res. Commun. 355 (2007), 895–901.
10. [10] Chang, C.H., Huang, Y.L., Shyu, M.K., Chen, S.U., Lin, C.H., Ju, T.K., Lu, J., Lee, H., Sphingosine-1-phosphate induces VEGF-C expression through a MMP-2/FGF-1/FGFR-1-dependent pathway in endothelial cells in vitro. Acta Pharmacol. Sin. 34 (2013), 360–366.
11. [11] Huang, Y.T., Chen, S.U., Chou, C.H., Lee, H., Sphingosine 1-phosphate induces platelet/endothelial cell adhesion molecule-1 phosphorylation in human endothelial cells through cSrc and Fyn. Cell. Signal. 20 (2008), 1521–1527.
12. [12] A. Ushiyama, H. Kataoka, T. Iijima, Glycocalyx and its involvement in clinical pathophysiologies, 2016, 4, 59.
13. [13] Tarbell, J.M., Pahakis, M.Y., Mechanotransduction and the glycocalyx. J. Intern. Med. 259 (2006), 339–350.
14. [14] Zeng, Y., Adamson, R.H., Curry, F.R., Tarbell, J.M., Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am. J. Physiol. Heart Circ. Physiol. 306 (2014), H363–H372.
15. [15] Zhang, L., Zeng, M., Fan, J., Tarbell, J.M., Curry, F.R., Fu, B.M., Sphingosine-1-phosphate maintains normal vascular permeability by preserving endothelial surface glycocalyx in intact microvessels. Microcirculation (New York, NY: 1994) 23 (2016), 301–310.
16. [16] Popova, T.G., Millis, B., Bailey, C., Popov, S.G., Platelets, inflammatory cells, von Willebrand factor, syndecan-1, fibrin, fibronectin, and bacteria co-localize in the liver thrombi of Bacillus anthracis-infected mice. Microb. Pathog. 52 (2012), 1–9.
17. [17] Aper, T., Haverich, A., Teebken, O., New developments in tissue engineering of vascular prosthetic grafts. VASA Zeitschrift fur Gefasskrankheiten 38 (2009), 99–122.
18. [18] Udelsman, B.V., Maxfield, M.W., Breuer, C.K., Tissue engineering of blood vessels in cardiovascular disease: moving towards clinical translation. Heart (British Cardiac Society) 99 (2013), 454–460.
19. [19] Hoenig, M.R., Campbell, G.R., Rolfe, B.E., Campbell, J.H., Tissue-engineered blood vessels: alternative to autologous grafts?. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 1128–1134.
20. [20] Isenberg, B.C., Williams, C., Tranquillo, R.T., Small-diameter artificial arteries engineered in vitro. Circ. Res. 98 (2006), 25–35.
21. [21] Dardik, H., Ibrahim, I.M., Baier, R., Sprayregen, S., Levy, M., Dardik, I.I., Human umbilical cord. A new source for vascular prosthesis. J. Am. Med. Assoc. 236 (1976), 2859–2862.
22. [22] Dardik, H., Wengerter, K., Qin, F., Pangilinan, A., Silvestri, F., Wolodiger, F., Kahn, M., Sussman, B., Ibrahim, I.M., Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases. J. Vasc. Surg. 35 (2002), 64–71.
23. [23] Daniel, J., Abe, K., McFetridge, P.S., Development of the human umbilical vein scaffold for cardiovascular tissue engineering applications. ASAIO J. 51 (2005), 252–261.
24. [24] Hoenicka, M., Lehle, K., Jacobs, V.R., Schmid, F.X., Birnbaum, D.E., Properties of the human umbilical vein as a living scaffold for a tissue-engineered vessel graft. Tissue Eng. 13 (2007), 219–229.
25. [25] Kazmi, R.S., Boyce, S., Lwaleed, B.A., Homeostasis of hemostasis: the role of endothelium. Semin. Thromb. Hemost. 41 (2015), 549–555.
26. [26] Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., Isner, J.M., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85 (1999), 221–228.
27. [27] Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., Isner, J.M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997), 964–967.
28. [28] Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., Finkel, T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003), 593–600.
29. [29] Lin, Y., Weisdorf, D.J., Solovey, A., Hebbel, R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105 (2000), 71–77.
30. [30] Leor, J., Marber, M., Endothelial progenitors: a new Tower of Babel?. J. Am. Coll. Cardiol. 48 (2006), 1588–1590.
31. [31] Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., Bohm, M., Nickenig, G., Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 (2005), 999–1007.
32. [32] Sales, K.M., Salacinski, H.J., Alobaid, N., Mikhail, M., Balakrishnan, V., Seifalian, A.M., Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol. 23 (2005), 461–467.
33. [33] Murohara, T., Ikeda, H., Duan, J., Shintani, S., Sasaki, K., Eguchi, H., Onitsuka, I., Matsui, K., Imaizumi, T., Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105 (2000), 1527–1536.
34. [34] Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P.H., Verfaillie, C.M., Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109 (2002), 337–346.
35. [35] Wang, H., Cai, K.Y., Li, W., Huang, H., Sphingosine-1-phosphate induces the migration and angiogenesis of Epcs through the Akt signaling pathway via sphingosine-1-phosphate receptor 3/platelet-derived growth factor receptor-beta. Cell. Mol. Biol. Lett. 20 (2015), 597–611.
36. [36] Gui, L., Chan, S.A., Breuer, C.K., Niklason, L.E., Novel utilization of serum in tissue decellularization. Tissue Eng. Part C, Methods 16 (2010), 173–184.
37. [37] Schaner, P.J., Martin, N.D., Tulenko, T.N., Shapiro, I.M., Tarola, N.A., Leichter, R.F., Carabasi, R.A., Dimuzio, P.J., Decellularized vein as a potential scaffold for vascular tissue engineering. J. Vasc. Surg. 40 (2004), 146–153.
38. [38] Huang, N., Chen, Y.R., Luo, J.M., Yi, J., Lu, R., Xiao, J., Xue, Z.N., Liu, X.H., In vitro investigation of blood compatibility of Ti with oxide layers of rutile structure. J. Biomater. Appl. 8 (1994), 404–412.
39. [39] Gui, L., Muto, A., Chan, S., Breuer, C., Niklason, L., Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng. 15 (2009), 2665–2676.
40. [40] Metcalfe, P., Williamson, L.M., Reutelingsperger, C.P., Swann, I., Ouwehand, W.H., Goodall, A.H., Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br. J. Haematol. 98 (1997), 86–95.
41. [41] Li, Q., Park, P.W., Wilson, C.L., Parks, W.C., Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111 (2002), 635–646.
42. [42] Xu, X.X., Gao, X.H., Pan, R., Lu, D., Dai, Y., A simple adhesion assay for studying interactions between platelets and endothelial cells in vitro. Cytotechnology 62 (2010), 17–22.
43. [43] McLarty, A.J., Phillips, M.R., Holmes, D.R. Jr., Schaff, H.V., Aortocoronary bypass grafting with expanded polytetrafluoroethylene: 12-year patency. Ann. Thorac. Surg. 65 (1998), 1442–1444.
44. [44] Takagi, H., Goto, S.N., Matsui, M., Manabe, H., Umemoto, T., A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting. J. Vasc. Surg. 52 (2010), 232–236.
45. [45] Faries, P.L., Logerfo, F.W., Arora, S., Hook, S., Pulling, M.C., Akbari, C.M., Campbell, D.R., Pomposelli, F.B. Jr., A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J. Vasc. Surg. 32 (2000), 1080–1090.
46. [46] Klinkert, P., Post, P.N., Breslau, P.J., van Bockel, J.H., Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur. J. Vasc. Endovasc. Surg. 27 (2004), 357–362.
47. [47] Robinson, D.R., Varcoe, R.L., Chee, W., Subramaniam, P.S., Benveniste, G.L., Fitridge, R.A., Long-term follow-up of last autogenous option arm vein bypass. ANZ J. Surgery 83 (2013), 769–773.
48. [48] Roll, S., Muller-Nordhorn, J., Keil, T., Scholz, H., Eidt, D., Greiner, W., Willich, S.N., Dacron vs. PTFE as bypass materials in peripheral vascular surgery–systematic review and meta-analysis. BMC Surgery, 8, 2008, 22.
49. [49] Stroncek, J.D., Grant, B.S., Brown, M.A., Povsic, T.J., Truskey, G.A., Reichert, W.M., Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers. Tissue Eng. Part A 15 (2009), 3473–3486.
50. [50] Herring, M.B., Endothelial cell seeding. J. Vasc. Surg. 13 (1991), 731–732.
51. [51] Alobaid, N., Salacinski, H.J., Sales, K.M., Hamilton, G., Seifalian, A.M., Single stage cell seeding of small diameter prosthetic cardiovascular grafts. Clin. Hemorheol. Microcirculation 33 (2005), 209–226.
52. [52] Baker, K.S., Williams, S.K., Jarrell, B.E., Koolpe, E.A., Levine, E., Endothelialization of human collagen surfaces with human adult endothelial cells. Am. J. Surg. 150 (1985), 197–200.
53. [53] Goissis, G., Suzigan, S., Parreira, D.R., Maniglia, J.V., Braile, D.M., Raymundo, S., Preparation and characterization of collagen-elastin matrices from blood vessels intended as small diameter vascular grafts. Artif. Organs 24 (2000), 217–223.
54. [54] Stansby, G., Berwanger, C., Shukla, N., Schmitz-Rixen, T., Hamilton, G., Endothelial seeding of compliant polyurethane vascular graft material. Br. J. Surgery 81 (1994), 1286–1289.
55. [55] Dutoya, S., Verna, A., Lefebvre, F., Rabaud, M., Elastin-derived protein coating onto poly(ethylene terephthalate). Technical, microstructural and biological studies. Biomaterials 21 (2000), 1521–1529.
56. [56] Kruger, A., Fuhrmann, R., Jung, F., Franke, R.P., Influence of the coating with extracellular matrix and the number of cell passages on the endothelialization of a polystyrene surface. Clin. Hemorheol. Microcirculation 60 (2015), 153–161.
57. [57] Schulz, C., Hecht, J., Kruger-Genge, A., Kratz, K., Jung, F., Lendlein, A., Generating aptamers interacting with polymeric surfaces for biofunctionalization. Macromol. Biosci. 16 (2016), 1776–1791.
58. [58] Mayer, A., Roch, T., Kratz, K., Lendlein, A., Jung, F., Pro-angiogenic CD14(++) CD16(+) CD163(+) monocytes accelerate the in vitro endothelialization of soft hydrophobic poly (n-butyl acrylate) networks. Acta Biomater. 8 (2012), 4253–4259.
59. [59] Gui, L., Muto, A., Chan, S.A., Breuer, C.K., Niklason, L.E., Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng. Part A 15 (2009), 2665–2676.
60. [60] Chung, M.C., Jorgensen, S.C., Popova, T.G., Bailey, C.L., Popov, S.G., Neutrophil elastase and syndecan shedding contribute to antithrombin depletion in murine anthrax. FEMS Immunol. Med. Microbiol. 54 (2008), 309–318.
61. [61] Johansson, P.I., Stensballe, J., Rasmussen, L.S., Ostrowski, S.R., A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 254 (2011), 194–200.
62. [62] Walter, D.H., Rochwalsky, U., Reinhold, J., Seeger, F., Aicher, A., Urbich, C., Spyridopoulos, I., Chun, J., Brinkmann, V., Keul, P., Levkau, B., Zeiher, A.M., Dimmeler, S., Haendeler, J., Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 275–282.
63. [63] Arya, D., Chang, S., DiMuzio, P., Carpenter, J., Tulenko, T.N., Sphingosine-1-phosphate promotes the differentiation of adipose-derived stem cells into endothelial nitric oxide synthase (eNOS) expressing endothelial-like cells. J. Biomed. Sci., 21, 2014, 55.